FDA Approves New Weight-Management Drug
December 24, 2014
The US Food and Drug Administration (FDA) has approved liraglutide (rDNA origin [Saxenda]) injection as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.
The drug is approved for use in adults with a body mass index (BMI) of ≥30 or adults with a BMI of ≥27 who have at least 1 weight-related condition such as hypertension, type 2 diabetes or dyslipidaemia.
http://dgnews.docguide.com/fda-approves ... newsletter
FDA одобрила liraglutide для лечения ожирения
Модератор: Pyankov Vasily
-
- Сообщения: 5564
- Зарегистрирован: Пн ноя 24, 2008 12:59 am
- Откуда: Киров
FDA одобрила liraglutide для лечения ожирения
Пьянков Василий Алексеевич